Concepts (115)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Urokinase Plasminogen Activator | 7 | 2019 | 21 | 1.060 |
Why?
|
| Renal Insufficiency, Chronic | 4 | 2018 | 89 | 0.520 |
Why?
|
| Proteinuria | 3 | 2018 | 57 | 0.310 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 3 | 2014 | 33 | 0.300 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 2 | 2018 | 34 | 0.290 |
Why?
|
| Myocardial Ischemia | 2 | 2021 | 42 | 0.280 |
Why?
|
| Heart Diseases | 2 | 2018 | 57 | 0.250 |
Why?
|
| Thrombosis | 2 | 2018 | 52 | 0.250 |
Why?
|
| Podocytes | 3 | 2019 | 41 | 0.220 |
Why?
|
| Bone Marrow Transplantation | 2 | 2012 | 23 | 0.200 |
Why?
|
| Atrial Appendage | 2 | 2018 | 40 | 0.180 |
Why?
|
| Firearms | 1 | 2019 | 1 | 0.170 |
Why?
|
| Social Control, Formal | 1 | 2019 | 1 | 0.170 |
Why?
|
| Civil Rights | 1 | 2019 | 3 | 0.170 |
Why?
|
| Ownership | 1 | 2019 | 7 | 0.160 |
Why?
|
| Coronary Thrombosis | 1 | 2019 | 4 | 0.160 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2019 | 13 | 0.160 |
Why?
|
| Plasma Exchange | 1 | 2018 | 10 | 0.160 |
Why?
|
| Image Enhancement | 1 | 2018 | 46 | 0.160 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2018 | 38 | 0.160 |
Why?
|
| Contrast Media | 1 | 2018 | 60 | 0.160 |
Why?
|
| Diagnostic Imaging | 1 | 2019 | 72 | 0.160 |
Why?
|
| Vascular Calcification | 1 | 2018 | 9 | 0.150 |
Why?
|
| Kidney Diseases | 1 | 2019 | 102 | 0.150 |
Why?
|
| C-Reactive Protein | 1 | 2018 | 99 | 0.150 |
Why?
|
| Apolipoproteins | 1 | 2017 | 7 | 0.150 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2014 | 40 | 0.150 |
Why?
|
| Mental Disorders | 1 | 2019 | 126 | 0.150 |
Why?
|
| Lipoproteins, HDL | 1 | 2017 | 21 | 0.140 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2017 | 15 | 0.140 |
Why?
|
| Myeloid Cells | 1 | 2016 | 8 | 0.140 |
Why?
|
| Hospitalization | 1 | 2019 | 294 | 0.140 |
Why?
|
| Male | 11 | 2021 | 14162 | 0.130 |
Why?
|
| Coronary Artery Disease | 1 | 2018 | 133 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 171 | 0.130 |
Why?
|
| Female | 11 | 2021 | 14539 | 0.130 |
Why?
|
| Myocardial Infarction | 2 | 2014 | 136 | 0.120 |
Why?
|
| Middle Aged | 8 | 2019 | 8601 | 0.120 |
Why?
|
| Humans | 14 | 2021 | 26286 | 0.110 |
Why?
|
| Cicatrix | 1 | 2014 | 8 | 0.110 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2014 | 13 | 0.110 |
Why?
|
| Risk Factors | 4 | 2021 | 2265 | 0.110 |
Why?
|
| Prospective Studies | 4 | 2018 | 1668 | 0.110 |
Why?
|
| Cardiomyopathies | 1 | 2012 | 34 | 0.100 |
Why?
|
| Thrombectomy | 1 | 2012 | 29 | 0.100 |
Why?
|
| Aged | 7 | 2019 | 8765 | 0.090 |
Why?
|
| Biomarkers | 3 | 2018 | 556 | 0.090 |
Why?
|
| Mice | 3 | 2019 | 1290 | 0.080 |
Why?
|
| Heart Failure | 1 | 2011 | 181 | 0.080 |
Why?
|
| Apolipoprotein L1 | 2 | 2018 | 6 | 0.080 |
Why?
|
| Mice, Transgenic | 2 | 2019 | 201 | 0.070 |
Why?
|
| Animals | 3 | 2019 | 3538 | 0.060 |
Why?
|
| Retrospective Studies | 3 | 2019 | 3367 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 574 | 0.060 |
Why?
|
| United States | 2 | 2021 | 1990 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2018 | 3391 | 0.050 |
Why?
|
| Adult | 3 | 2019 | 7448 | 0.050 |
Why?
|
| Adolescent | 2 | 2017 | 2080 | 0.050 |
Why?
|
| Transplantation, Autologous | 2 | 2012 | 160 | 0.050 |
Why?
|
| Sex Factors | 1 | 2021 | 450 | 0.040 |
Why?
|
| New York City | 1 | 2019 | 14 | 0.040 |
Why?
|
| Receptor, PAR-2 | 1 | 2019 | 3 | 0.040 |
Why?
|
| Protein Domains | 1 | 2019 | 7 | 0.040 |
Why?
|
| Adipocytes | 1 | 2019 | 12 | 0.040 |
Why?
|
| Protein Multimerization | 1 | 2019 | 16 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2019 | 46 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 2019 | 65 | 0.040 |
Why?
|
| Coronary Vessels | 1 | 2019 | 31 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2019 | 58 | 0.040 |
Why?
|
| Integrin beta3 | 1 | 2018 | 4 | 0.040 |
Why?
|
| Echocardiography | 1 | 2019 | 82 | 0.040 |
Why?
|
| Rituximab | 1 | 2018 | 50 | 0.040 |
Why?
|
| Immunologic Factors | 1 | 2018 | 32 | 0.040 |
Why?
|
| Biopsy | 1 | 2019 | 200 | 0.040 |
Why?
|
| Heart Ventricles | 1 | 2019 | 123 | 0.040 |
Why?
|
| Computed Tomography Angiography | 1 | 2018 | 29 | 0.040 |
Why?
|
| Coronary Angiography | 1 | 2018 | 72 | 0.040 |
Why?
|
| Recurrence | 1 | 2018 | 314 | 0.040 |
Why?
|
| Renal Replacement Therapy | 1 | 2017 | 22 | 0.040 |
Why?
|
| Surface Plasmon Resonance | 1 | 2017 | 4 | 0.040 |
Why?
|
| Kidney Transplantation | 1 | 2018 | 120 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2016 | 39 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2019 | 409 | 0.030 |
Why?
|
| Alleles | 1 | 2017 | 201 | 0.030 |
Why?
|
| Kidney Failure, Chronic | 1 | 2018 | 151 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2016 | 26 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2016 | 50 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 460 | 0.030 |
Why?
|
| Kidney Glomerulus | 1 | 2016 | 48 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 679 | 0.030 |
Why?
|
| Genotype | 1 | 2017 | 335 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2016 | 268 | 0.030 |
Why?
|
| Prognosis | 1 | 2018 | 758 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2018 | 629 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 374 | 0.030 |
Why?
|
| Disease Progression | 1 | 2017 | 687 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 723 | 0.030 |
Why?
|
| Muscle Development | 1 | 2014 | 4 | 0.030 |
Why?
|
| Time Factors | 1 | 2018 | 1391 | 0.030 |
Why?
|
| Injections | 1 | 2014 | 44 | 0.030 |
Why?
|
| Tomography, Spiral Computed | 1 | 2014 | 27 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 1157 | 0.030 |
Why?
|
| Stroke Volume | 1 | 2014 | 62 | 0.030 |
Why?
|
| Child | 1 | 2017 | 1236 | 0.030 |
Why?
|
| Ventricular Remodeling | 1 | 2012 | 4 | 0.030 |
Why?
|
| HLA Antigens | 1 | 2012 | 15 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 1738 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2017 | 1838 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2012 | 287 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 1886 | 0.020 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2011 | 6 | 0.020 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2011 | 16 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2011 | 400 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 4675 | 0.020 |
Why?
|
| Quality of Life | 1 | 2012 | 621 | 0.020 |
Why?
|